Cargando…
Standard-Intensity Versus Low-Intensity Anticoagulation with Warfarin in Asian Patients with Atrial Fibrillation: A Multi-Center, Randomized Controlled Trial
Anticoagulation with warfarin in Asian patients with atrial fibrillation (AF) often has been decreased as an international normalized ratio (INR) of prothrombin time 1.6-2.6 due to fear of bleeding, although universal criteria recommend an INR of 2.0-3.0. In this randomized, open-label trial, low-in...
Autores principales: | Cho, Jeong Gwan, Lee, Ki Hong, Kim, Yoo Ri, Kim, Sunah, Gwak, Jisoo, Cho, Eunbit, Sin, Yourim, Shin, Seung Yong, Park, Hyung Wook, Ko, Jum Suk, Kim, Nam Ho, Park, Yae Min, Lee, Jung Myung, Yoon, Nam Sik, Kim, Sung Soo, Kim, Jun Hyung, Kim, Dong Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126601/ https://www.ncbi.nlm.nih.gov/pubmed/37082789 http://dx.doi.org/10.1177/10760296231171081 |
Ejemplares similares
-
What is Standard Dose of Rivaroxaban in Elderly Asian Patients with Atrial Fibrillation: 20ms versus. 15mg?
por: Kim, Sung Soo, et al.
Publicado: (2021) -
Impact of Anticoagulation Intensity in Korean Patients with Atrial Fibrillation: Is It Different from Western Population?
por: Lee, Ki Hong, et al.
Publicado: (2019) -
Safety and effectiveness of anticoagulation with non-vitamin K antagonist oral anticoagulants and warfarin in patients on tuberculosis treatment
por: Lee, Hyun-Jung, et al.
Publicado: (2023) -
Optimal anticoagulation intensity with warfarin for the prevention of thromboembolism with minimal bleeding in Asian patients with atrial fibrillation: multi-center, randomized controlled trial
por: Lee, K H, et al.
Publicado: (2023) -
Real World Comparison of Rivaroxaban and Warfarin in Korean Patients with Atrial Fibrillation: Propensity Matching Cohort Analysis
por: Jeong, Hyung Ki, et al.
Publicado: (2019)